SW

Case studies

Real-world impact, measured in outcomes.

A selection of engagements where strategy met execution — and the numbers moved.

Industry

Service

An airline's journey from insolvency to profitability

Aviation · Strategy & Corporate Finance

An airline's journey from insolvency to profitability

Challenge

A regional carrier facing liquidity collapse, fragmented operations, and eroding customer trust needed a credible 24-month path back to profitability.

Solution

We led a balance-sheet restructuring in parallel with network redesign, dynamic pricing rollout, and a frontline service overhaul — sequenced to protect cash while rebuilding the brand.

Outcome

The carrier returned to positive EBITDA within eleven months and exited restructuring fourteen months ahead of plan, with NPS at a five-year high.

+$182M
EBITDA swing
94%
On-time performance
+38 pts
NPS lift
Resetting a flagship retail format for the next decade

Retail · Retail Consulting

Resetting a flagship retail format for the next decade

Challenge

A premium retailer's flagship stores were losing share to digital-native competitors, with conversion declining for nine consecutive quarters.

Solution

We rebuilt the in-store journey end-to-end — assortment, fixtures, associate model, and clienteling tools — piloted across four flagships before national rollout.

Outcome

Same-store sales returned to double-digit growth within two quarters, with the pilots outperforming control stores by 14 points on conversion.

+11.4%
Same-store sales
+18%
Conversion lift
212
Stores rolled out
Launching a specialty therapy under accelerated review

Life Sciences · Corporate Pharmaceutical Services

Launching a specialty therapy under accelerated review

Challenge

A mid-cap biotech needed to compress an 18-month commercial launch plan into nine months following accelerated regulatory review.

Solution

We stood up a parallel-track launch program covering payer access, field-force design, supply assurance, and medical-affairs readiness — with weekly executive governance.

Outcome

The therapy launched on the accelerated timeline with 92% payer coverage at month six and exceeded year-one revenue targets by 23%.

9 months
Time to launch
92%
Payer coverage at M6
+23%
Y1 revenue vs plan